Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Parkinsonism with dementia of Guadeloupe is characterized by symmetrical bradykinesia, predominantly axial rigidity, postural instability with early falls and cognitive decline with prominent features of frontal lobe dysfunction.
Features include very common findings: Parkinsonism, Muscle stiffness (rigidity), and Slowness of movement (bradykinesia); and common findings: Vertical supranuclear gaze palsy, Hypometric saccades, Progressive loss of mental abilities (dementia), and Frontal lobe dementia and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 15 | Parkinsonism, Muscle stiffness (rigidity), Slowness of movement (bradykinesia) |
Biomarker and diagnostic research for parkinsonism with dementia of Guadeloupe has been reported in the published literature.
Phenotype severity distribution: 3 very common features, 23 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for parkinsonism with dementia of Guadeloupe.
10 publications have been identified in PubMed for parkinsonism with dementia of Guadeloupe. Research spans Epidemiology / Natural History (70%), Diagnostic / Biomarker (20%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 70% |
Data assembled from 4 of 12 sources · Last updated Sep 21, 2026, 4:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 3 | Cerebral cortical atrophy, EMG: myopathic abnormalities, Weakness due to upper motor neuron dysfunction |
Eyes | 1 | Hypometric saccades |
Bones and joints | 1 | Postural instability |
Testing and diagnosis research
2 |
20% |
Clinical study results | 1 | 10% |
Ribeyron L (2026). [PMID: 42192274](https://pubmed.ncbi.nlm.nih.gov/42192274/). *Behav Neurol*. [Clinical Trial Publication]
Boucaud-Maitre D (2025). [PMID: 39979372](https://pubmed.ncbi.nlm.nih.gov/39979372/). *Scientific reports*. [Epidemiology / Natural History]
Boucaud-Maitre D (2025). [PMID: 39775330](https://pubmed.ncbi.nlm.nih.gov/39775330/). *PloS one*. [Epidemiology / Natural History]
Boucaud-Maitre D (2025). [PMID: 41344708](https://pubmed.ncbi.nlm.nih.gov/41344708/). *BMJ open*. [Diagnostic / Biomarker]
Tabué-Teguo M (2025). [PMID: 40128462](https://pubmed.ncbi.nlm.nih.gov/40128462/). *Aging clinical and experimental research*. [Epidemiology / Natural History]
Tabue Teguo M (2024). [PMID: 39064650](https://pubmed.ncbi.nlm.nih.gov/39064650/). *Nutrients*. [Epidemiology / Natural History]
Boucaud-Maitre D (2024). [PMID: 39355845](https://pubmed.ncbi.nlm.nih.gov/39355845/). *Frontiers in medicine*. [Epidemiology / Natural History]
Boucaud-Maitre D (2024). [PMID: 38905295](https://pubmed.ncbi.nlm.nih.gov/38905295/). *PloS one*. [Epidemiology / Natural History]
Boucaud-Maitre D (2024). [PMID: 39087204](https://pubmed.ncbi.nlm.nih.gov/39087204/). *Innovation in aging*. [Epidemiology / Natural History]
Houot M (2024). [PMID: 39443529](https://pubmed.ncbi.nlm.nih.gov/39443529/). *Scientific reports*. [Diagnostic / Biomarker]